STRATIFICATION OF KNEE OSTEOARTHRITIS: TO THE PROBLEM OF PHENOTYPES
Vol. 30 No. 2 (2022), Review articles
Vol. 30 No. 2 (2022)

STRATIFICATION OF KNEE OSTEOARTHRITIS: TO THE PROBLEM OF PHENOTYPES

Review articles
https://doi.org/10.35465/30.2.2022.pp28-43
Published August 24, 2022
Kristina Valerjevna Korochina
PhD, Senior teacher of Department of Internal Medicine, Orenburg State Medical University
Tatyana Viktorovna Chernysheva
PhD, Head of Department of Internal Medicine, Orenburg State Medical University
http://orcid.org/0000-0001-9645-5816
Irina Eduardovna Korochina
PhD, Associate Professor of Outpatient Therapy Department, Orenburg State Medical University
http://orcid.org/0000-0001-9956-4508
Irina Alekseevna Krivotulova
Assistant of Department of Internal Medicine, Orenburg State Medical University
http://orcid.org/0000-0002-1530-4205
Andrey Aleksandrovich Averyanov
PhD, Head of Department of Traumatology and Orthopedics, Orenburg State Medical University
http://orcid.org/0000-0003-2739-8605
Marina Vladimirovna Stolbova
PhD, Associate Professor of Department of Internal Medicine, Orenburg State Medical University
http://orcid.org/0000-0002-7536-0209
PDF

Keywords

Osteoarthritis, stratification, classification, phenotypes, endotypes.

How to Cite

Korochina, K., Chernysheva, T., Korochina, I., Krivotulova, I., Averyanov, A., & Stolbova, M. (2022). STRATIFICATION OF KNEE OSTEOARTHRITIS: TO THE PROBLEM OF PHENOTYPES. Rheumatology (Bulgaria), 30(2), 35-50. https://doi.org/10.35465/30.2.2022.pp28-43
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The presented review is devoted to the actual problem of knee osteoarthritis (OA) stratification and consists of descriptive and systemic analysis parts. In the first part, the evolution of OA concepts and the development of phenotypic approach is reflected. It is noted that OA followed long path from age-related “wear and tear” to inflammatory disease with high heterogeneity, which triggered enormous number of attempts to group this disease in the last decade. As no unified approach has been proposed in its classifying, rheumatology has collected an abundance of ambiguous data obtained in studies on knee OA. Recent advances in phenotyping made obvious the need to systematize proposed earlier classifications and to evaluate their compliance with the modern concept, which was done in the second part of review. Systematic search strategy was used in the referenced databases MEDLINE/PubMed and Google Scholar without a time frame with the following keywords "osteoarthritis", "phenotypes", "classification", "subtypes", "subsets", "subgroups", "endotypes", and 58 different classifications were extracted, analyzed and stratified into the following boxes: phenotypes, endotypes, and other classifications. Among the proposed OA classifications, clinical groups were the most common, followed by structural, laboratory, molecular, genetic, and progression trajectories. Only few of proposed OA kinds can rightly be called phenotypes whereas most of classifications aimed to distinguish predictors or risk factors for this disease. It can be assured that the variety of accumulated information will soon lead us to novel approaches of phenotype-associated management strategy for OA patients.

https://doi.org/10.35465/30.2.2022.pp28-43
PDF

References

  1. Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37 Suppl 120(5):3-6
  2. Sapundzhiev L, Sapundzhieva T, Klinkanov K. Osteoarthritis – а modern concept of etiology and pathogenesis. Rheumatology (Bulgaria). 2021. Vol. XХIX, No 1:32-43 doi: 10.35465/29.1.2021.pp21-43
  3. Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022;30(2):184-195. doi: 10.1016/j.joca.2021.04.020
  4. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039-1049. doi:10.1002/art.1780290816
  5. Kraus VB, Blanco FJ, Englund M, et al. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage. 2015;23(8):1233-41. doi: 10.1016/j.joca.2015.03.036
  6. Alekseeva LI, Kashevarova NG, Taskina EA. Osteoarthritis. Clinical guidelines of the Ministry of Health. 2016 (In Russ.)
  7. Dell'Isola A, Allan R, Smith SL, et al. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet Disord. 2016;17(1):425. doi:10.1186/s12891-016-1286-2
  8. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-388. doi:10.1016/j.joca.2014.01.003
  9. Herrero-Beaumont G, Roman-Blas JA, Castañeda S, Jimenez SA. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum. 2009;39(2):71-80. doi:10.1016/j.semarthrit.2009.03.006
  10. Waarsing JH, Bierma-Zeinstra SM, Weinans H. Distinct subtypes of knee osteoarthritis: data from the Osteoarthritis Initiative. Rheumatology (Oxford). 2015;54(9):1650-1658. doi:10.1093/rheumatology/kev100
  11. Frey-Law LA, Bohr NL, Sluka KA, et al. Pain sensitivity profiles in patients with advanced knee osteoarthritis. Pain. 2016;157(9):1988-1999. doi:10.1097/j.pain.0000000000000603
  12. Roze RH, Bierma-Zeinstra SM, Agricola R, et al. Differences in MRI features between two different osteoarthritis subpopulations: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2016;24(5):822-826. doi:10.1016/j.joca.2015.12.006
  13. Werdyani S, Liu M, Zhang H, et al. Endotypes of primary osteoarthritis identified by plasma metabolomics analysis. Rheumatology (Oxford). 2020 Nov 7:keaa693. doi: 10.1093/rheumatology/keaa693
  14. Lila AM, Alekseeva LI, Telyshev KA. Current approaches to osteoarthritis phenotyping. Modern Rheumatology Journal. 2019;13(2):4-8. (In Russ.) doi:10.14412/1996-7012-2019-2-4-8
  15. Karsdal MA, Christiansen C, Ladel C, et al. Osteoarthritis--a case for personalized health care? Osteoarthritis Cartilage. 2014;22(1):7-16. doi:10.1016/j.joca.2013.10.018
  16. Deveza LA, Nelson AE, Loeser RF. Phenotypes of osteoarthritis: current state and future implications. Clin Exp Rheumatol. 37 Suppl 2019;120(5):64-72.
  17. Jeremiasse B, Welsing PMJ, Fellows C, et al. Identification of biochemical phenotypes in knee osteoarthritis: longitudinal data from the FNIH OA biomarker consortium. Ann Rheum Dis. 2017;76(Suppl 2):964.1-964. doi:10.1136/annrheumdis-2017-eular.5825
  18. Carlson AK, Rawle RA, Wallace CW, et al. Characterization of synovial fluid metabolomic phenotypes of cartilage morphological changes associated with osteoarthritis. Osteoarthritis Cartilage. 2019;27(8):1174-1184. doi:10.1016/j.joca.2019.04.007
  19. Knoop J, van der Leeden M, Thorstensson CA, et al. Identification of phenotypes with different clinical outcomes in knee osteoarthritis: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken). 2011;63(11):1535-1542. doi:10.1002/acr.20571
  20. van der Esch M, Knoop J, van der Leeden M, et al. Clinical phenotypes in patients with knee osteoarthritis: a study in the Amsterdam osteoarthritis cohort. Osteoarthritis Cartilage. 2015;23(4):544-549. doi:10.1016/j.joca.2015.01.006
  21. Musumeci G, Aiello FC, Szychlinska MA, et al. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 2015;6(3):6093-6112. doi:10.3390/ijms16036093
  22. Herrero-Beaumont G, Roman-Blas JA, Bruyère O, et al. Clinical settings in knee osteoarthritis: Pathophysiology guides treatment. Maturitas. 2017;96:54-57. doi:10.1016/j.maturitas.2016.11.013
  23. Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337-350. doi:10.1016/j.semarthrit.2019.04.008
  24. van Spil WE, Bierma-Zeinstra SMA, Deveza LA, et al. A consensus-based framework for conducting and reporting osteoarthritis phenotype research. Arthritis Res Ther. 2020;22(1):54. doi:10.1186/s13075-020-2143-0
  25. Van Spil WE, Kubassova O, Boesen M, et al. Osteoarthritis phenotypes and novel therapeutic targets. Biochem Pharmacol. 2019;165:41-48. doi: 10.1016/j.bcp.2019.02.037
  26. de Campos GC, Tieppo AM, de Almeida CS Jr, et al. Target-based approach for osteoarthritis treatment. World J Orthop. 2020;11(6):278-284. doi: 10.5312/wjo.v11.i6.278
  27. Berenbaum F. Deep phenotyping of osteoarthritis: a step forward. Ann Rheum Dis. 2019;78(1):3-5. doi: 10.1136/annrheumdis-2018-213864
  28. Roman-Blas JA, Mendoza-Torres LA, Largo R, Herrero-Beaumont G. Setting up distinctive outcome measures for each osteoarthritis phenotype. Ther Adv Musculoskelet Dis. 2020;12:1759720X20937966. doi: 10.1177/1759720X20937966
  29. Deveza LA, Melo L, Yamato TP, et al. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthritis Cartilage. 2017;25(12):1926-1941. doi:10.1016/j.joca.2017.08.009
  30. Dorio M, Deveza LA. Phenotypes in Osteoarthritis: why do we need them and where are we at? Clin Geriatr Med. 2022;38(2):273-286. doi: 10.1016/j.cger.2021.11.002
  31. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31(11):1409-17. doi: 10.1007/s00296-011-1999-3
  32. Kittelson AJ, Schmiege SJ, Maluf K, et al. Determination of pain phenotypes in knee osteoarthritis using latent profile analysis. Pain Med. 2021;22(3):653-662. doi:10.1093/pm/pnaa398
  33. Mantripragada VP, Csorba A, Bova W, et al. Assessment of clinical, tissue, and cell-level metrics identify four biologically distinct knee osteoarthritis patient phenotypes. Cartilage. 2022;13(1):19476035221074003. doi: 10.1177/19476035221074003
  34. Peat G, Duncan RC, Wood LR, et al. Clinical features of symptomatic patellofemoral joint osteoarthritis. Arthritis Res Ther. 2012;14(2):R63. doi:10.1186/ar3779
  35. Angelini F, Widera P, Mobasheri A, et al. Osteoarthritis endotype discovery via clustering of biochemical marker data. Ann Rheum Dis. 2022;81(5):666-675. doi: 10.1136/annrheumdis-2021-221763
  36. Kabalyk MA, Gnedenkov SV, Kovalenko TS et al. Molecular subtypes of osteoarthritis. Pacific Medical Journal. 2017;(4):40-44. (In Russ.) doi:10.17238/PmJ1609-1175.2017.4.40-44
  37. Mobasheri A, van Spil WE, Budd E, et al. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Curr Opin Rheumatol. 2019;31(1):80-89. doi: 10.1097/BOR.0000000000000567
  38. Cruz-Almeida Y, King CD, Goodin BR, et al. Psychological profiles and pain characteristics of older adults with knee osteoarthritis. Arthritis Care Res (Hoboken). 2013;65(11):1786-1794. doi:10.1002/acr.22070
  39. Jenkins JB, McCoy TP. Symptom clusters, functional status, and quality of life in older adults with osteoarthritis. Orthop Nurs. 2015;34(1):36-44. doi:10.1097/NOR.0000000000000112
  40. Murphy SL, Lyden AK, Phillips K, et al. Subgroups of older adults with osteoarthritis based upon differing comorbid symptom presentations and potential underlying pain mechanisms. Arthritis Res Ther. 2011;13(4):R135. doi:10.1186/ar3449
  41. Cardoso JS, Riley JL 3rd, Glover T, et al. Experimental pain phenotyping in community-dwelling individuals with knee osteoarthritis. Pain. 2016;157(9):2104-2114. doi:10.1097/j.pain.0000000000000625
  42. Carlesso LC, Neogi T. Identifying pain susceptibility phenotypes in knee osteoarthritis. Clin Exp Rheumatol. 37 Suppl 2019;120(5):96-99.
  43. Egsgaard LL, Eskehave TN, Bay-Jensen AC, et al. Identifying specific profiles in patients with different degrees of painful knee osteoarthritis based on serological biochemical and mechanistic pain biomarkers: a diagnostic approach based on cluster analysis. Pain. 2015;156(1):96-107. doi:10.1016/j.pain.0000000000000011
  44. Hoogeboom TJ, den Broeder AA, Swierstra BA, et al. Joint-pain comorbidity, health status, and medication use in hip and knee osteoarthritis: a cross-sectional study. Arthritis Care Res (Hoboken). 2012;64(1):54-58. doi:10.1002/acr.20647
  45. Lee S, Kim TN, Kim SH, et al. Obesity, metabolic abnormality, and knee osteoarthritis: a cross-sectional study in Korean women. Mod Rheumatol. 2015;25(2):292-297. doi:10.3109/14397595.2014.939393
  46. Lentz TA, Hellkamp AS, Bhavsar NA, et al. Assessment of common comorbidity phenotypes among older adults with knee osteoarthritis to inform integrated care models. Mayo Clin Proc Innov Qual Outcomes. 2021;5(2):253-264. doi: 10.1016/j.mayocpiqo.2020.09.011
  47. Kabakchieva P, Georgiev T, Gateva A, et al. Polycystic ovary syndrome and (pre)osteoarthritis: assessing the link between hyperandrogenism in young women and cartilage oligomeric matrix protein as a marker of cartilage breakdown. Clin Rheumatol. 2021;40(10):4217-4223. doi: 10.1007/s10067-021-05753-0
  48. Vongsirinavarat M, Nilmart P, Somprasong S, Apinonkul B. Identification of knee osteoarthritis disability phenotypes regarding activity limitation: a cluster analysis. BMC Musculoskelet Disord. 2020;21(1):237. doi:10.1186/s12891-020-03260-y
  49. Elbaz A, Mor A, Segal G, et al. Novel classification of knee osteoarthritis severity based on spatiotemporal gait analysis. Osteoarthritis Cartilage. 2014;22(3):457-463. doi:10.1186/ar3299
  50. Bastick AN, Wesseling J, Damen J, et al. Defining knee pain trajectories in early symptomatic knee osteoarthritis in primary care: 5-year results from a nationwide prospective cohort study (CHECK). Br J Gen Pract. 2016;66(642):e32-e39. doi:10.3399/bjgp15X688129
  51. Collins JE, Katz JN, Dervan EE, Losina. Trajectories and risk profiles of pain in persons with radiographic, symptomatic knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthritis Cartilage. 2014;22(5):622-630. doi:10.1016/j.joca.2014.03.009
  52. Radojčić MR, Arden NK, Yang X, et al. Pain trajectory defines knee osteoarthritis subgroups: a prospective observational study [published online ahead of print, 2020 Jun 24]. Pain. 2020;10.1097/j.pain.0000000000001975. doi:10.1097/j.pain.0000000000001975
  53. Kosinskaja NS. Degenerative-dystrophic lesions of osteoarticular apparatus 1961;L:Medgiz:202 (In Russ.)
  54. Makushin VD, Chegourov OK. Gonarthrosis (the problems of pathogenesis and classification). The Ilizarov Journal of Clinical and Experimental Orthopedics. 2005;2:19-22 (In Russ.)
  55. Driban JB, McAlindon TE, Amin M, et al. Risk factors can classify individuals who develop accelerated knee osteoarthritis: Data from the osteoarthritis initiative. J Orthop Res. 2018;36(3):876-880. doi:10.1002/jor.23675
  56. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957;16(4):494-502. doi:10.1136/ard.16.4.494
  57. Kinds MB, Marijnissen AC, Viergever MA, et al. Identifying phenotypes of knee osteoarthritis by separate quantitative radiographic features may improve patient selection for more targeted treatment. J Rheumatol. 2013;40(6):891-902. doi:10.3899/jrheum.121004
  58. Nelson AE, Fang F, Arbeeva L, et al. A machine learning approach to knee osteoarthritis phenotyping: data from the FNIH Biomarkers Consortium. Osteoarthritis Cartilage. 2019;27(7):994-1001. doi:10.1016/j.joca.2018.12.027
  59. Holla JF, van der Leeden M, Heymans MW, et al. Three trajectories of activity limitations in early symptomatic knee osteoarthritis: a 5-year follow-up study. Ann Rheum Dis. 2014;73(7):1369-1375. doi:10.1136/annrheumdis-2012-202984
  60. Abhishek A, Doherty S, Maciewicz RA, et al. Does Chondrocalcinosis Associate With a Distinct Radiographic Phenotype of Osteoarthritis in Knees and Hips? A Case-Control Study. Arthritis Care Res (Hoboken). 2016;68(2):211-216. doi:10.1002/acr.22652
  61. Demirag MD, Ozkan S, Haznedaroglu S, et al. Associations between obesity and the radiographic phenotype in knee osteoarthritis. Turk J Med Sci. 2017;47(2):424-429. doi: 10.3906/sag-1512-26
  62. Kabalyk MA, Nevzorova VA. Identification of structural phenotypes of osteoarthritis. Department of Traumatology and Orthopedics. 2019;1(35):11-16. (In Russ). doi: 10.17238/issn2226-2016.2019.1.11-16
  63. Roemer FW, Collins J, Kwoh CK, et al. MRI-based screening for structural definition of eligibility in clinical DMOAD trials: Rapid OsteoArthritis MRI Eligibility Score (ROAMES). Osteoarthritis Cartilage. 2020;28(1):71-81. doi:10.1016/j.joca.2019.08.005
  64. McGonagle D, Tan AL, Carey J, Benjamin M. The anatomical basis for a novel classification of osteoarthritis and allied disorders. J Anat. 2010;216(3):279-291. doi:10.1111/j.1469-7580.2009.01186.x
  65. Wyatt LA, Moreton BJ, Mapp PI, et al. Histopathological subgroups in knee osteoarthritis. Osteoarthritis Cartilage. 2017;25(1):14-22. doi:10.1016/j.joca.2016.09.021
  66. Iijima H, Fukutani N, Aoyama T, et al. Clinical phenotype classifications based on static varus alignment and varus thrust in japanese patients with medial knee osteoarthritis. Arthritis Rheumatol. 2015;67(9):2354-2362. doi:10.1002/art.39224
  67. Attur M, Belitskaya-Lévy I, Oh C, et al. Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum. 2011;63(7):1908-1917. doi:10.1002/art.30360
  68. Ji Q, Zheng Y, Zhang G, et al. Single-cell RNA-seq analysis reveals the progression of human osteoarthritis. Ann Rheum Dis. 2019;78(1):100-110. doi:10.1136/annrheumdis-2017-212863
  69. Meulenbelt I, Kloppenburg M, Kroon HM, et al. Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. Osteoarthritis Cartilage. 2007;15(4):379-385. doi:10.1016/j.joca.2006.09.007
  70. Siebuhr AS, Petersen KK, Arendt-Nielsen L, et al. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover. Osteoarthritis Cartilage. 2014;22(1):44-50. doi:10.1016/j.joca.2013.10.020
  71. Snelling SJ, Bas S, Puskas GJ, et al. Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype. PLoS One. 2017;12(4):e0175109. doi:10.1371/journal.pone.0175109
  72. Zhang W, Likhodii S, Zhang Y, et al. Classification of osteoarthritis phenotypes by metabolomics analysis. BMJ Open. 2014;4(11):e006286. doi:10.1136/bmjopen-2014-006286
  73. Mobasheri A, Saarakkala S, Finnilä M, et al. Recent advances in understanding the phenotypes of osteoarthritis. 2019;F1000Res 8:F1000 Faculty Rev-2091. doi:10.12688/f1000research.20575.1
  74. Georgiev Ts, Kabakchieva P. Polycystic ovary syndrome metabolic and hormonal dysfunction in relation to osteoarthritis onset and development: innocent bystander or major risk factor? Rheumatology (Bulgaria). 2021. Vol. 29 No. 2:45-51 doi: 10.35465/29.2.2021.pp40-51
  75. Ruiz-Romero C, Rego-Perez I, Blanco FJ. What did we learn from 'omics' studies in osteoarthritis. Curr Opin Rheumatol. 2018;30(1):114-120. doi: 10.1097/BOR.0000000000000460
  76. Mobasheri A, Kapoor M, Amanda Ali S, et al. The future of deep phenotyping in osteoarthritis: How can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease? Osteoarthritis Cartilage. 2021;3:100144. doi: 10.1016/j.ocarto.2021.100144
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.